Prescription Drug Monitoring Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Mar 22, 2021)
Prescription Drug Monitoring Act of 2021
This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs.
States or territories that receive this funding must require
- prescribers to consult the PDMP before starting treatment with such drugs, and
- dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs.
In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.
What just happenedMar 22, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
- Introduced in SenateMar 22, 2021
- Mar 22, 2021IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - Mar 22, 2021IntroReferral10000
Introduced in Senate